Brief: CanSino Biologics' Prelim 2024 Net Loss At 378.9 Million Yuan
27/02/2025 08:46
Feb 27 (Reuters) - CanSino Biologics Inc 688185.SS: SAYS PRELIM 2024 NET LOSS AT 378.9 MILLION YUAN ($52.11 million) Source text Further company coverage: 688185.SS ($1 = 7.2716 Chinese yuan renminbi) (Reporting by Beijing Newsroom) ((Ethan.Wang@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025